Savillex, LLC has completed its acquisition of Entegris, Inc.'s Life Sciences Fluid Management business, the Eden Prairie, Minnesota-based fluid handling supplier said. The acquired business was part of Billerica, Massachusetts-based Entegris.
Savillex describes itself as a provider of high-purity fluid handling solutions for life science and laboratory applications worldwide. The company said the acquired portfolio is used across discovery, clinical and commercial manufacturing, and that the transaction adds complementary products and expertise to its existing business.
The purchase adds a portfolio of bioprocessing and pharmaceutical manufacturing solutions, including Aramus products, PE bags, single-use assemblies and components used in discovery, clinical and commercial manufacturing. Savillex said the acquisition broadens its life sciences offerings with more high-performance single-use products.
Savillex also gains the Life Sciences Fluid Management team and its technologies in high-purity fluid management. According to the company, customers can expect a wider set of single-use solutions, more technical expertise and added capabilities for applications from early-stage research through commercial manufacturing. Savillex said the combined strengths are intended to help customers manage increasingly complex bioprocessing workflows.
Leadership views
Chief executive officer Eric Giesing said the Life Sciences Fluid Management business has established a reputation in high-purity single-use bioprocessing, and he described the Aramus line as a fit with Savillex's existing Savillex, Containment and Bioprocessing offerings. He said the transaction expands the company's portfolio and its ability to serve biopharmaceutical and pharmaceutical customers with a broader range of solutions. Giesing also said Savillex is welcoming the acquired team and will continue investing in technologies intended to help customers speed development and production of critical therapies.
Chris Bedi, general manager of Fluid Management at Savillex, said the acquisition creates an opportunity to offer a broader portfolio of high-value fluid management solutions to pharmaceutical and biopharmaceutical customers worldwide. He said the Fluid Management portfolio complements Savillex's existing capabilities, and the combined organization will continue to provide innovative solutions while expanding support for partners across drug development. Bedi said the company aims to help customers bring new medicines to patients.
Strategy and advisors
Savillex said the acquisition advances its strategy of providing industry-leading solutions for the life sciences market. The company said it remains committed to investing in innovation, quality and customer partnerships as it expands its portfolio for biopharmaceutical and pharmaceutical manufacturers.
Terms of the transaction were not disclosed. EC M&A of New York served as financial advisor to Savillex, and Sidley Austin LLP of Chicago served as legal counsel.